Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms

This publication has 15 references indexed in Scilit:

• Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial
  European Urology, 2016
• Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
  The Lancet Oncology, 2015
• Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011
  European Urology, 2013
• The absence of voiding symptoms in men with a prostate‐specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial
  BJU International, 2012
• Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men
  European Urology, 2011
• Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial
  American Journal of Epidemiology, 2011
• Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
  European Urology, 2009
• Awareness of Prostate Cancer among the General Public: Findings of an Independent International Survey
  European Urology, 2003
• Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project
  European Urology, 2002
• Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence
  BJU International, 2000